To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3813 | Ntrd22 |
Novel Allosteric Modulator of RNA Binding Targeting the N-Terminal Domain of TDP-43
More description
|
|
| DCC3812 | Ntrc-808 |
Novel nonpeptide potent and selective partial agonist of the Neurotensin receptor type 2 (NTS2)
More description
|
|
| DCC3811 | Ntrc-739 |
Novel nonpeptide selective ligand for NTS2
More description
|
|
| DCC3810 | Nti-007 |
Potent anti-HBV agent, targeting the NTCP-APOA1-HBx-Beclin1-mediated autophagic pathway
More description
|
|
| DCC3809 | Nsp-116 |
Novel free radical scavenger, against light-induced photoreceptor cell damage
More description
|
|
| DCC3808 | Nsmase2-in-1 |
Novel inhibitor of neutral sphingomyelinase 2 (nSMase2) for the treatment of neurodegenerative diseases
More description
|
|
| DCC3807 | Nsi-189 Phosphate |
Novel stimulator of neurogenesis of human hippocampus-derived neural stem cells in vitro and in vivo.
More description
|
|
| DCC3806 | nsc-96626 |
Novel B-Raf(V600E) inhibitor
More description
|
|
| DCC3805 | Nsc-9037 |
First-in-class probe of Rad6 function, inhibiting Rad6 function and Rad6-Rad18 interaction in the PCNA ubiquitination cascade
More description
|
|
| DCC3804 | Nsc-8891 |
Tyrosyl-DNA phosphodiesterase (Tdp1) inhibitor
More description
|
|
| DCC3803 | Nsc-84096 |
Potent inhibitor of endopeptidase activity of botulinum neurotoxin type A light chain (rBoNT/A-LC)
More description
|
|
| DCC3802 | Nsc-80141 |
Selective inhibitor of HsEg5
More description
|
|
| DCC3801 | Nsc-79887 |
Novel inhibitor of nucleoside hydrolase (NH)
More description
|
|
| DCC3800 | Nsc-77053 |
The first reported BoNT/E small molecule inhibitor
More description
|
|
| DCC3799 | Nsc750212 |
Novel inhibitor of lipid metabolism, disrupting tubulin polymerization,suppressing monoglycerol metabolism depleting lipids and inhibiting the growth of both lymphoma and RCC both in vitro and in vivo
More description
|
|
| DCC3798 | Nsc747854 |
Novel inhibitor of poly (ADP-ribose) polymerase-1 (PARP-1)
More description
|
|
| DCC3797 | nsc746365 Maleate |
Telomerase inhibitor, anticancer agent
More description
|
|
| DCC3796 | nsc746364 |
Telomerase inhibitor, stabilizing G-quadruplex and suppressing cell growth of A549 human lung cancer cells through activation of the ATR/Chk1-dependent pathway
More description
|
|
| DCC3795 | Nsc745885 |
Novel down-regulator of EZH2, inducing G2/M cell-cycle arrest of cancer cells and degradating p53 via proteasome-dependent and -independent pathways
More description
|
|
| DCC3794 | Nsc-741909 |
Novel anticancer agent, suppressing the growth of several cell lines derived from lung, colon, breast, ovarian, and kidney cancers
More description
|
|
| DCC3793 | Nsc-73306 |
Cytotoxic MDR-selective ligand
More description
|
|
| DCC3792 | Nsc724527 |
Novel Inhibitor of HCV NS3/4A Proteinase
More description
|
|
| DCC3791 | Nsc724526 |
Novel Inhibitor of HCV NS3/4A Proteinase
More description
|
|
| DCC3790 | Nsc705841 |
Novel selective serotonin reuptake inhibitor (SSRI), exhibiting higher binding affinities in comparison with the paroxetine
More description
|
|
| DCC3789 | Nsc704342 |
Novel Inhibitor of HCV NS3/4A Proteinase
More description
|
|
| DCC3788 | Nsc-689857 |
Novel inhibitor of the Skp2-Cks1 protein-protein interaction and p27Kip1 ubiquitination in vitro
More description
|
|
| DCC3787 | nsc-681152 |
Novel inhibitor of the Skp2-Cks1 protein-protein interaction and p27(Kip1) ubiquitination in vitro
More description
|
|
| DCC3786 | Nsc676914a |
Novel NF-κB inhibitor
More description
|
|
| DCC3785 | Nsc-674205 |
Potent and selective nociceptin opioid receptor (NOP) agonist
More description
|
|
| DCC3784 | Nsc-672121 |
Potent CDC25A>Cdc25A inhibitor; Vitamine K3 analogue
More description
|
|